DB
Daniel D. Billadeau

Elite Scholar


395
Works
20,333
Citations
80
H-Index
Search Authors
Author Statistics

Daniel D. Billadeau

Also known as: Billadeau, Daniel D., D Billadeau, D D Billadeau, D. Billadeau, D. D. BILLADEAU

395

Total Works

20,333

Citations

80

H-Index

208

i10-Index

Citation & Works Trend by Year
36 years active
Top Research Topics
Protein Kinase Regulation and GTPase Signaling (105) Pancreatic and Hepatic Oncology Research (100) Cellular transport and secretion (85) Signaling Pathways in Disease (76) T-cell and B-cell Immunology (54)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 VAV1 targeting for cancer therapeutics: mechanistic understanding and preclinical promise Expert Opinion on Therapeutic Targets 0
2026 TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo Journal of Clinical Investigation 0
2026 TAF7 accumulates in the cytoplasm during cellular transformation and engages STAT3, WASH, and CCT Frontiers in Cell and Developmental Biology 0
2026 PD-1 regulates latent effector differentiation of thymic cytotoxic CD8+ T cells Nature Communications 1
2026 Mini-Galaxy: Rethinking Complex Human Diseases Through the Lens of Systems Biology and Multilayered AI Network Perspectives International Journal of Molecular Sciences 0
2026 Bronchiectasis and chronic active EBV (CAEBV) as first signs of IRF8-deficiency Klinische Pädiatrie 0
2026 Going Deep: The Power of Deep Learning to Uncover Disease-Driven Protein–Protein Interactions and Accelerate Drug Design Challenges and advances in computational chemistry and physics 0
2025 T cells use TNF and IFNγ for paracrine killing with target discrimination programmed by pathogen-derived factors bioRxiv (Cold Spring Harbor Laboratory) 1
2025 Nuclear VAV1 increases GLI1-dependent transcription in pancreatic cancer cells Journal of Biological Chemistry 1
2025 Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy 0
2025 Supplementary Figure from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy 0
2025 Supplementary Figures S1-S12 from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM 0
2025 Data from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM 0
2025 Supplementary Table S3 from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM 0
2025 Supplementary Table S1 from Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM 0

Data source: OpenAlex API